Jefferson Health

Physician Profile

Maria Werner-Wasik, MD

Jefferson University Physician

Academic Title: Professor
Director, Clinical Research
Co-Director, Thoracic Oncology Program

Specialties
Radiation Oncology
Radiation Oncology - Brain Tumor
Radiation Oncology - Leukemia/Lymphoma
Radiation Oncology - Lung Cancer
Radiation Oncology - Melanoma/Skin Cancer
Radiation Oncology - Soft Tissue Sarcoma
Radiation Oncology - Spinal Cord Tumors

Make An Appointment

Click to call 1-800-JEFF-NOW (800-533-3669) or

Office Locations

Philadelphia
Bodine Center, Suite G-301
111 South 11th Street
Philadelphia PA 19107
Phone: (215) 955-6702
Fax: (215) 955-0412

Medical Services

Years in Practice

23

Board Certifications

  • Radiation Oncology
  • Internal Medicine

Hospital Affiliation / Admitting Privileges

  • Thomas Jefferson University Hospital

Awards and Honors

Philadelphia Magazine's Top Docs 2016,2015,2014,2013,2012,2011,2010

Education

  • Wroclaw Medical Academy, Poland, Medical School

Internship

  • Framingham Union Hospital-MA

Residency

  • Tufts/New England Medical Center
  • New England Medical Center

Fellowship

  • Hospital of the University of Pennsylvania

Recent Publications

Comparison of Online 6 Degree-of-Freedom Image Registration of Varian TrueBeam Cone-Beam CT and BrainLab ExacTrac X-Ray for Intracranial Radiosurgery

Spheno-Orbital Meningiomas: An Analysis Based on World Health Organization Classification and Ki-67 Proliferative Index

Predictors and Patterns of Regional Recurrence Following Lung SBRT: A Report From the Elekta Lung Research Group

Neutrophil to lymphocyte ratio associated with prognosis of lung cancer

Reply to M.C. Chamberlain

Stereotactic Body Radiation Therapy in Octo- and Nonagenarians for the Treatment of Early-Stage Lung Cancer

Dose to heart substructures is associated with non-cancer death after SBRT in stage I-II NSCLC patients

Validation of High-Risk Computed Tomography Features for Detection of Local Recurrence After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer

Pretreatment 18F-FDG PET textural features in locally advanced non-small cell lung cancer: Secondary analysis of ACRIN 6668/RTOG 0235

Phase I and II study of induction chemotherapy with methotrexate, rituximab, and temozolomide, followed by whole-brain radiotherapy and postirradiation temozolomide for primary CNS lymphoma: NRG oncology RTOG 0227

Phase I trial of panobinostat and fractionated stereotactic re-irradiation therapy for recurrent high grade gliomas

Plan quality and treatment efficiency for radiosurgery to multiple brain metastases: Non-coplanar rapidarc vs. Gamma Knife

Dosimetric validation for an automatic brain metastases planning software using single-isocenter dynamic conformal arcs

Prediction of early death in patients with early-stage NSCLC - Can we select patients without a potential benefit of SBRT as a curative treatment approach?

Re-resection for recurrent high-grade glioma in the setting of re-irradiation: more is not always better

Fractionated Stereotactic Radiotherapy for Facial Nerve Schwannomas

Evaluation of Elekta 4D cone beam CT-based automatic image registration for radiation treatment of lung cancer

Active Breathing Coordinator reduces radiation dose to the heart and preserves local control in patients with left breast cancer: Report of a prospective trial

Tumor volume threshold for achieving improved conformity in VMAT and Gamma Knife stereotactic radiosurgery for vestibular schwannoma

Pretreatment FDG-PET metrics in stage III non-small cell lung cancer: ACRIN 6668/RTOG 0235